Skip to content
GenoLensGenoLens

PGAP2

Chr 11p15.4

post-GPI attachment to proteins 2

Aliases:
FRAG1, CWH43-N
MANE:
ENST00000278243.9

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Congenital disorders of glycosylation

    BIALLELIC, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset dystonia, chorea or related movement disorder

  • Clefting

    Unknown

Disease associations (Open Targets)

  • hyperphosphatasia-intellectual disability syndrome

    0.73
  • Intellectual disability

    0.60
  • hereditary disease

    0.34
  • genetic developmental and epileptic encephalopathy

    0.27
  • Dysequilibrium syndrome

    0.27
  • familial hemolytic anemia

    0.18
  • omphalocele

    0.12
  • Micrognathia

    0.12
  • Hypoplasia of the corpus callosum

    0.12
  • amelogenesis imperfecta

    0.08

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Acyltransferase PGAP2

Involved in the fatty acid remodeling steps of GPI-anchor maturation where the unsaturated acyl chain at sn-2 of inositol phosphate is replaced by a saturated stearoyl chain. May catalyze the second step of the fatty acid remodeling, by reacylating a lyso-GPI intermediate at sn-2 of inositol phosphate by a saturated chain (By similarity). The fatty acid remodeling steps is critical for the integration of GPI-APs into lipid rafts (PubMed:23561846)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.